Serré, Jef
Tanjeko, Ajime Tom
Mathyssen, Carolien
Heigl, Tobias
Sacreas, Annelore
Cook, Dana Paulina
Verbeken, Erik
Maes, Karen
Verhaegen, Jan
Pilette, Charles
Vanoirbeek, Jeroen
Gysemans, Conny
Mathieu, Chantal
Vanaudenaerde, Bart
Janssens, Wim
Gayan-Ramirez, Ghislaine http://orcid.org/0000-0001-9652-7437
Funding for this research was provided by:
Onderzoeksraad, KU Leuven (C24/15/30)
Article History
Received: 9 February 2021
Accepted: 17 February 2022
First Online: 2 March 2022
Declarations
:
: All experimental procedures were conducted according to the European, national and institutional guidelines for animal welfare and approved by the Ethical Committee of Animal Experiments of the KU Leuven (authorization number: P050/2016 and P082/2016). COPD patients were issued from a previous single-center, double-blind, randomized, placebo-controlled trial (RCT) (University hospitals Leuven, Belgium) and was approved by the local ethics committee of University Hospital of Leuven (S50722, EudraCT number: 2007-004755-11) and ClinicalTrials.gov (NCT00666367).
: Not applicable.
: None of the other authors of this manuscript have any conflicts of interest to disclose in relation with this manuscript. The authors confirm that the work described has not been published previously, that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form in English or in any other language, without the written consent of the copyright holder.